Gilead Sciences Inc. (GILD) Lobbying Data
GILD lobbying summary
Gilead Sciences Inc (GILD) has reported $89.5M in federal lobbying spending across 362 Senate LDA filings since 2020. Its most frequent lobbying issues are Health Issues, Medicare/Medicaid, Budget/Appropriations, Trade. Lobbying firms used include Gilead Sciences, Inc., Jeffrey J. Kimbell & Associates, Inc., Capitol Tax Partners, LLP.
Lobbying spending by year
| Year | Reported spend |
|---|---|
| 2026 | $16.5M |
| 2025 | $11.5M |
| 2024 | $12.2M |
| 2023 | $11.3M |
| 2022 | $17.2M |
| 2021 | $10.9M |
See insider trading for GILD or the Lobbying Heavyweights strategy.
Source: Senate Lobbying Disclosure Act (LD-2) filings. The current year is partial.